BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26211680)

  • 1. Phosphodiesterase 4D: an enzyme to remember.
    Ricciarelli R; Fedele E
    Br J Pharmacol; 2015 Oct; 172(20):4785-9. PubMed ID: 26211680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
    Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
    Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
    Jin SL; Ding SL; Lin SC
    Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
    Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
    Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders.
    Bhat A; Ray B; Mahalakshmi AM; Tuladhar S; Nandakumar DN; Srinivasan M; Essa MM; Chidambaram SB; Guillemin GJ; Sakharkar MK
    Pharmacol Res; 2020 Oct; 160():105078. PubMed ID: 32673703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
    Mika D; Conti M
    Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice.
    Rutten K; Misner DL; Works M; Blokland A; Novak TJ; Santarelli L; Wallace TL
    Eur J Neurosci; 2008 Aug; 28(3):625-32. PubMed ID: 18702734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
    Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
    Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases.
    McCahill AC; Huston E; Li X; Houslay MD
    Handb Exp Pharmacol; 2008; (186):125-66. PubMed ID: 18491051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.
    Tibbo AJ; Tejeda GS; Baillie GS
    Biochem Soc Trans; 2019 Oct; 47(5):1557-1565. PubMed ID: 31642904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.
    Omar F; Findlay JE; Carfray G; Allcock RW; Jiang Z; Moore C; Muir AL; Lannoy M; Fertig BA; Mai D; Day JP; Bolger G; Baillie GS; Schwiebert E; Klussmann E; Pyne NJ; Ong ACM; Bowers K; Adam JM; Adams DR; Houslay MD; Henderson DJP
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13320-13329. PubMed ID: 31209056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss.
    Hansen RT; Zhang HT
    Adv Neurobiol; 2017; 17():169-199. PubMed ID: 28956333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
    Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
    Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
    Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
    Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
    Wang Y; Zhang Y; Li Y; Huang J
    Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
    Jeong MH; Urquhart G; Lewis C; Chi Z; Jewell JL
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.
    Roy D; Balasubramanian S; Krishnamurthy PT; Sola P; Rymbai E
    Cell Mol Neurobiol; 2023 Aug; 43(6):2713-2741. PubMed ID: 37074485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.